🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/12/2010 | 33,68 | 33,73 | 33,44 | 33,64 | -0,14% | 0,85% | 11.176.082 |
| 03/12/2010 | 33,67 | 33,70 | 33,42 | 33,68 | +0,23% | 0,85% | 11.352.774 |
| 02/12/2010 | 33,55 | 33,74 | 33,41 | 33,61 | +0,46% | 1,00% | 39.504.255 |
| 01/12/2010 | 33,16 | 33,51 | 33,08 | 33,45 | +1,71% | 1,29% | 34.710.598 |
| 30/11/2010 | 32,87 | 33,10 | 32,75 | 32,89 | -0,63% | 1,07% | 40.543.452 |
| 29/11/2010 | 33,00 | 33,15 | 32,72 | 33,10 | -0,29% | 1,30% | 13.967.220 |
| 26/11/2010 | 32,94 | 33,29 | 32,92 | 33,20 | -1,02% | 1,13% | 7.456.101 |
| 24/11/2010 | 33,23 | 33,56 | 33,22 | 33,54 | +0,98% | 1,03% | 11.182.894 |
| 23/11/2010 | 33,72 | 33,76 | 33,12 | 33,22 | -2,19% | 1,90% | 19.217.176 |
| 22/11/2010 | 33,86 | 34,01 | 33,57 | 33,96 | +0,74% | 1,30% | 15.256.050 |
| 19/11/2010 | 33,68 | 33,74 | 33,32 | 33,71 | +0,11% | 1,25% | 16.375.105 |
| 18/11/2010 | 33,53 | 33,72 | 33,25 | 33,67 | +2,38% | 1,39% | 16.417.654 |
| 17/11/2010 | 33,22 | 34,02 | 32,87 | 32,89 | +1,08% | 3,45% | 20.993.746 |
| 16/11/2010 | 32,74 | 32,86 | 32,39 | 32,54 | -1,27% | 1,46% | 23.091.213 |
| 15/11/2010 | 33,12 | 33,36 | 32,94 | 32,96 | -0,49% | 1,27% | 13.741.795 |
| 12/11/2010 | 33,44 | 33,45 | 32,81 | 33,12 | -1,42% | 1,91% | 24.896.602 |
| 11/11/2010 | 33,30 | 33,79 | 33,25 | 33,60 | +0,71% | 1,60% | 14.792.939 |
| 10/11/2010 | 33,44 | 33,57 | 33,19 | 33,36 | -0,26% | 1,14% | 19.982.216 |
| 09/11/2010 | 33,92 | 34,10 | 33,38 | 33,44 | -1,60% | 2,14% | 22.320.933 |
| 08/11/2010 | 34,02 | 34,17 | 33,94 | 33,99 | -0,22% | 0,67% | 14.344.186 |
| 05/11/2010 | 34,99 | 35,06 | 33,80 | 34,06 | -2,59% | 3,60% | 23.583.144 |
| 04/11/2010 | 35,17 | 35,26 | 34,77 | 34,97 | +0,38% | 1,38% | 12.430.433 |
| 03/11/2010 | 35,05 | 35,09 | 34,39 | 34,84 | -0,27% | 1,99% | 9.966.690 |
| 02/11/2010 | 34,90 | 35,17 | 34,84 | 34,93 | +0,99% | 0,96% | 10.462.813 |
| 01/11/2010 | 34,77 | 35,05 | 34,33 | 34,59 | -0,17% | 2,06% | 10.131.540 |
| 29/10/2010 | 35,05 | 35,06 | 34,37 | 34,65 | -1,71% | 1,96% | 15.961.669 |
| 28/10/2010 | 34,99 | 35,36 | 34,98 | 35,25 | +1,32% | 1,09% | 10.344.074 |
| 27/10/2010 | 35,19 | 35,19 | 34,48 | 34,79 | -1,65% | 2,03% | 12.701.131 |
| 26/10/2010 | 35,60 | 35,62 | 35,20 | 35,37 | -0,94% | 1,18% | 7.444.363 |
| 25/10/2010 | 35,59 | 35,95 | 35,58 | 35,71 | +0,86% | 1,05% | 11.167.488 |